Andrew Scharenberg

Founder at

Umoja Biopharma, Inc.

Health Technology

Finance

Consumer Services

Profile

Andrew M Scharenberg is the founder of Generation Bio Co. (2017) and Umoja Biopharma, Inc. (2019) where the title held is Chief Executive Officer & Director.
Current job is with MPM BioImpact LLC as Entrepreneur Partner since 2019.
Former jobs include Advisor at bluebird bio, Inc. (2014-2017), Chief Scientific Officer at Cellectis, Inc. (2011-2014), and Chief Scientific Officer at Casebia Therapeutics LLC (2017-2019).
Education includes a doctorate from UNC School of Medicine (1993).

Andrew Scharenberg active positions

Companies	Position	Start
Umoja Biopharma, Inc. Umoja Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for treatment of cancer therapies	Founder	2018-12-31
MPM BioImpact LLC MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions.	Private Equity Investor	2019-05-31

All active positions of Andrew Scharenberg

Former positions of Andrew Scharenberg

Companies	Position	End
Casebia Therapeutics LLC Casebia Therapeutics LLC Pharmaceuticals: GenericHealth Technology Discovers, develops and commercializes gene-editing therapeutics to treat the genetic causes of bleeding disorders, autoimmune disease	Corporate Officer/Principal	2019-07-31
GENETIX BIOTHERAPEUTICS, INC.	Consultant / Advisor	2017-05-31
Cellectis, Inc. Cellectis, Inc. Pharmaceuticals: MajorHealth Technology Engages in the upstream research of genome engineering and in the development of pre-engineered products for pharmaceutical industry, cell therapies, seed companies, and laboratory researchers	Corporate Officer/Principal	2014-06-29
GENERATION BIO CO.	Founder	-

See the detail of Andrew Scharenberg's experience

Training of Andrew Scharenberg

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Andrew Scharenberg's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	7
MPM BioImpact LLC MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions.	Finance
bluebird bio, Inc. bluebird bio, Inc. BiotechnologyHealth Technology Develops genetic therapies based on blood stem cells	Health Technology
UNC School of Medicine UNC School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Cellectis, Inc. Cellectis, Inc. Pharmaceuticals: MajorHealth Technology Engages in the upstream research of genome engineering and in the development of pre-engineered products for pharmaceutical industry, cell therapies, seed companies, and laboratory researchers	Health Technology
Generation Bio Co. Generation Bio Co. Pharmaceuticals: MajorHealth Technology Develops and commercializes genetic medicines	Health Technology
Casebia Therapeutics LLC Casebia Therapeutics LLC Pharmaceuticals: GenericHealth Technology Discovers, develops and commercializes gene-editing therapeutics to treat the genetic causes of bleeding disorders, autoimmune disease	Health Technology
Umoja Biopharma, Inc. Umoja Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for treatment of cancer therapies	Health Technology